Li trims its forecast to 24,500 vehicle deliveries for the third quarter from 25,000 to 26,000.

Supply-chain issues could make this Christmas season more challenging than normal for toymakers, a media report says.

AstraZeneca's breast-cancer treatment reduced the risk of disease progression or death by 72% vs. a currently approved treatment.

Twitter's payment would settle a shareholder lawsuit that the company misled investors about its user engagement totals.

Pharmacy giant CVS plans to add 25,000 ahead of flu season and coronavirus-related vaccinations.

Stocks could drop 20% as fiscal stimulus is withdrawn and economic growth slows, a Morgan Stanley strategist says.

Bitcoin and other cryptocurrencies are battered as China Evergrande Group struggles with bond obligations.

Brooks Automation is selling its chip solutions group and said it would no longer pursue splitting into two companies.

DR Horton said "significant disruptions in the supply chain ... along with tightness in the labor market" will lead to a modestly lower full-year sales forecast.

Colgate-Palmolive stock was upgraded to buy with an $86 price target at Deutsche Bank.